Effects of long-term supplementation with omega-3 fatty acids on longitudinal changes in bone mass and microstructure in mice.
Bonnet
Nicolas
N
Division of Bone Diseases, Department of Rehabilitation and Geriatrics, WHO Collaborating Center for Osteoporosis Prevention, Geneva University Hospital, 1211 Geneva 14, Switzerland. nicolas.bonnet@unige.ch
Ferrari
Serge L
SL
D000818:Animals; D015519:Bone Density / Q000187:drug effects*; D001842:Bone and Bones / Q000187:drug effects* / Q000378:metabolism / Q000648:ultrastructure*; D004042:Dietary Fats, Unsaturated / Q000494:pharmacology*; D004281:Docosahexaenoic Acids / Q000494:pharmacology*; D015118:Eicosapentaenoic Acid / Q000494:pharmacology*; D005260:Female; D007334:Insulin-Like Growth Factor I / Q000378:metabolism; D020738:Leptin / Q000378:metabolism; D051379:Mice; D015675:Osteocalcin / Q000378:metabolism
D004042:Dietary Fats, Unsaturated; D020738:Leptin; C519530:insulin-like growth factor-1, mouse; D015675:Osteocalcin; D004281:Docosahexaenoic Acids; D007334:Insulin-Like Growth Factor I; D015118:Eicosapentaenoic Acid